Dashboard
Manage Tickers

CECelanese Corp

NYSE celanese.com


$ 155.34 $ 1.73 (1.13 %)    

Wednesday, 01-May-2024 09:36:50 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 423.07 $ 0.92 (0.22 %)
DIA $ 379.15 $ 0.84 (0.22 %)
SPY $ 501.50 $ 0.50 (0.1 %)
TLT $ 88.54 $ 0.32 (0.36 %)
GLD $ 212.97 $ -0.09 (-0.04 %)
$ 153.61
$ 154.54
$ 0.00 x 0
$ 0.00 x 0
$ 154.54 - $ 155.41
$ 97.29 - $ 171.38
390,336
na
16.8B
$ 1.36
$ 8.57
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-23-2024 12-31-2023 10-K
2 11-08-2023 09-30-2023 10-Q
3 08-08-2023 06-30-2023 10-Q
4 05-10-2023 03-31-2023 10-Q
5 02-24-2023 12-31-2022 10-K
6 11-04-2022 09-30-2022 10-Q
7 07-29-2022 06-30-2022 10-Q
8 04-29-2022 03-31-2022 10-Q
9 02-10-2022 12-31-2021 10-K
10 10-22-2021 09-30-2021 10-Q
11 07-23-2021 06-30-2021 10-Q
12 04-23-2021 03-31-2021 10-Q
13 02-11-2021 12-31-2020 10-K
14 10-26-2020 09-30-2020 10-Q
15 07-29-2020 06-30-2020 10-Q
16 04-28-2020 03-31-2020 10-Q
17 02-06-2020 12-31-2019 10-K
18 10-22-2019 09-30-2019 10-Q
19 07-23-2019 06-30-2019 10-Q
20 04-23-2019 03-31-2019 10-Q
21 02-07-2019 12-31-2018 10-K
22 10-19-2018 09-30-2018 10-Q
23 07-20-2018 06-30-2018 10-Q
24 04-17-2018 03-31-2018 10-Q
25 02-09-2018 12-31-2017 10-K
26 10-17-2017 09-30-2017 10-Q
27 07-25-2017 06-30-2017 10-Q
28 04-18-2017 03-31-2017 10-Q
29 02-10-2017 12-31-2016 10-K
30 10-18-2016 09-30-2016 10-Q
31 07-26-2016 06-30-2016 10-Q
32 04-19-2016 03-31-2016 10-Q
33 02-05-2016 12-31-2015 10-K
34 10-20-2015 09-30-2015 10-Q
35 07-17-2015 06-30-2015 10-Q
36 04-17-2015 03-31-2015 10-Q
37 02-06-2015 12-31-2014 10-K
38 10-21-2014 09-30-2014 10-Q
39 07-18-2014 06-30-2014 10-Q
40 04-22-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

rbc-capital-maintains-outperform-on-celanese-raises-price-target-to-171
RBC Capital Maintains Outperform on Celane...
04/19/2024 17:44:42

RBC Capital analyst Arun Viswanathan maintains Celanese (NYSE:CE) with a Outperform and raises the price target from $165 to...

how-is-the-market-feeling-about-celanese
How Is The Market Feeling About Celanese?
04/12/2024 16:45:26

citigroup-maintains-neutral-on-celanese-raises-price-target-to-167
Citigroup Maintains Neutral on Celanese, R...
04/10/2024 17:51:32

Citigroup analyst Patrick Cunningham maintains Celanese (NYSE:CE) with a Neutral and raises the price target from $150 to $167.

a-closer-look-at-11-analyst-recommendations-for-celanese
A Closer Look at 11 Analyst Recommendation...
04/09/2024 13:00:27

keybanc-maintains-overweight-on-celanese-raises-price-target-to-190
Keybanc Maintains Overweight on Celanese, ...
04/09/2024 08:42:05

Keybanc analyst Aleksey Yefremov maintains Celanese (NYSE:CE) with a Overweight and raises the price target from $176 to $190.

barclays-downgrades-celanese-to-equal-weight-maintains-price-target-to-170
Barclays Downgrades Celanese to Equal-Weig...
04/04/2024 13:19:29

Barclays analyst Michael Leithead downgrades Celanese (NYSE:CE) from Overweight to Equal-Weight and maintains the price targ...

jp-morgan-downgrades-celanese-to-underweight-raises-price-target-to-160
JP Morgan Downgrades Celanese to Underweig...
04/04/2024 11:32:39

JP Morgan analyst Jeffrey Zekauskas downgrades Celanese (NYSE:CE) from Neutral to Underweight and raises the price target fr...

1000-invested-in-celanese-15-years-ago-would-be-worth-this-much-today
$1000 Invested In Celanese 15 Years Ago Wo...
04/01/2024 15:00:28

9-analysts-assess-celanese-what-you-need-to-know
9 Analysts Assess Celanese: What You Need ...
03/22/2024 16:00:16

wells-fargo-maintains-overweight-on-celanese-raises-price-target-to-195
Wells Fargo Maintains Overweight on Celane...
03/22/2024 15:37:43

Wells Fargo analyst Michael Sison maintains Celanese (NYSE:CE) with a Overweight and raises the price target from $180 to $195.

celanese-and-secarna-pharmaceuticals-enter-rna-research-collaboration-for-long-acting-antisense-therapies
Celanese and Secarna Pharmaceuticals Enter...
03/20/2024 13:03:22

heres-how-much-1000-invested-in-celanese-15-years-ago-would-be-worth-today
Here's How Much $1000 Invested In Celanese...
03/15/2024 14:00:18

how-is-the-market-feeling-about-celanese
How Is The Market Feeling About Celanese?
03/08/2024 16:45:18

Core News & Articles
Celanese Demonstrates Strong Performance a...
03/05/2024 15:05:20

1000-invested-in-this-stock-15-years-ago-would-be-worth-16000-today
$1000 Invested In This Stock 15 Years Ago ...
02/28/2024 15:30:28

celanese-upgrade-reflects-progress-as-debt-overhang-is-poised-to-wane-analyst
Celanese Upgrade 'Reflects Progress' As De...
02/26/2024 17:58:18

Shares of Celanese Corporation (NYSE: CE) maintained a downtrend in early trading on Monday.

rbc-capital-maintains-outperform-on-celanese-lowers-price-target-to-165
RBC Capital Maintains Outperform on Celane...
02/26/2024 15:27:59

RBC Capital analyst Arun Viswanathan maintains Celanese (NYSE:CE) with a Outperform and lowers the price target from $168 to...

piper-sandler-upgrades-celanese-to-overweight-raises-price-target-to-170
Piper Sandler Upgrades Celanese to Overwei...
02/26/2024 13:07:21

Piper Sandler analyst Charles Neivert upgrades Celanese (NYSE:CE) from Neutral to Overweight and raises the price target fro...

celanese-stock-a-deep-dive-into-analyst-perspectives-8-ratings
Celanese Stock: A Deep Dive Into Analyst P...
02/22/2024 17:00:26

wells-fargo-maintains-overweight-rating-for-celanese-heres-what-you-need-to-know
Wells Fargo Maintains Overweight Rating fo...
02/22/2024 17:00:14

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION